fda drug safety communication semaglutide naion 2025 The obesity (Wegovy) conferred a significantly higher risk of fda drug safety communication naion

Rapid dose escalation significantly increases the severity and duration of gastrointestinal side effects

Monitor health: Keep up with your healthcare appointments to monitor for side effects and track progress

Insurance authorization delays, pharmacy stock issues, and compounding lead times can create gaps that trigger appetite return and weight regain

In standard cooking amounts, saffron does not appear to cause adverse effects in humans

Understanding this recognised side effect helps patients and healthcare professionals anticipate and manage symptoms appropriately through hydration, dietary strategies, and simple analgesics when needed